close 74% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Home・Aandelen Lijst・Inovio Pharmaceuticals Inc
Search

Inovio Pharmaceuticals Inc

Gesloten

SectorGezondheidszorg

2.74 -4.2

Strong Buy

Prijsupdate 9 sep 2025, 19:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.67

Max

2.96

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+142.51% upside

Dividenden

By Dow Jones

Volgende Winsten

13 nov 2025

Nieuwssentiment

By Acuity

84%

16%

349 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

1.76 / 1.94 Steun & Weerstand

Inovio Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

9 sep 2025, 23:37 UTC

Populaire aandelen

Stocks to Watch: Oracle, Wearable Devices, GameStop

DJ

Lezen

9 sep 2025, 20:41 UTC

Winsten

Oracle's Backlog Surges With Major Customer Deals in 1Q

DJ

Lezen

9 sep 2025, 20:30 UTC

Winsten

GameStop 2Q Sales, Profit Rise

DJ

Lezen

9 sep 2025, 23:19 UTC

Marktinformatie

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

DJ

Lezen

9 sep 2025, 21:35 UTC

Winsten

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

DJ

Lezen

9 sep 2025, 21:32 UTC

Winsten

Oracle's Backlog Swells With Big Customer Deals -- Update

DJ

Lezen

9 sep 2025, 21:02 UTC

Acquisities, Fusies, Overnames

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

DJ

Lezen

9 sep 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

9 sep 2025, 20:33 UTC

Winsten

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

DJ

Lezen

9 sep 2025, 20:26 UTC

Winsten

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

DJ

Lezen

9 sep 2025, 20:23 UTC

Winsten

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

DJ

Lezen

9 sep 2025, 20:12 UTC

Winsten

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

DJ

Lezen

9 sep 2025, 20:10 UTC

Winsten

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

DJ

Lezen

9 sep 2025, 20:10 UTC

Winsten

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

DJ

Lezen

9 sep 2025, 20:09 UTC

Winsten

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

DJ

Lezen

9 sep 2025, 20:09 UTC

Winsten

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

DJ

Lezen

9 sep 2025, 20:08 UTC

Winsten

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

DJ

Lezen

9 sep 2025, 20:08 UTC

Winsten

Oracle 1Q Operating Income Was $4.3 B >ORCL

DJ

Lezen

9 sep 2025, 20:08 UTC

Winsten

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

DJ

Lezen

9 sep 2025, 20:08 UTC

Winsten

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

DJ

Lezen

9 sep 2025, 20:07 UTC

Winsten

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

DJ

Lezen

9 sep 2025, 20:06 UTC

Winsten

Oracle 1Q Software Revenue $5.72B >ORCL

DJ

Lezen

9 sep 2025, 20:06 UTC

Winsten

Synopsys 3Q Adj EPS $3.39 >SNPS

DJ

Lezen

9 sep 2025, 20:06 UTC

Winsten

Oracle 1Q Cloud Revenue $7.19B >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q Rev $14.93B >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q EPS $1.01 >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Synopsys 3Q EPS $1.50 >SNPS

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q Services Revenue $1.35B >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q Adj EPS $1.47 >ORCL

DJ

Lezen

9 sep 2025, 20:05 UTC

Winsten

Oracle 1Q Hardware Revenue $670M >ORCL

DJ

Lezen

Peer Vergelijking

Prijswijziging

Inovio Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

142.51% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6.96 USD  142.51%

Hoogste 13 USD

Laagste 1.8 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Inovio Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

4

Buy

1

Hold

0

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Inovio Pharmaceuticals Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

1.76 / 1.94Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

349 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

749.85

↑ +1.61%

JNJ

Johnson and Johnson

177.08

↓-0.6%

ABBV

AbbVie Inc

210.45

↑ +0.22%

UNH

UnitedHealth Group Inc

348.61

↑ +8.84%

NVO

Novo Nordisk A-S

54.26

↓-0.09%
help-icon Live chat